Autism Spectrum Disorder Treatment Market Size, Share & Industry Analysis, By Treatment Type (Communication & Behavioral Therapies {Applied Behavior Analysis (ABA), Speech & Language Therapy, Occupational Therapy, and Others} and Drug Therapies {Antipsychotic Drugs, Selective Serotonin Reuptake Inhibitors, Stimulants, Sleep Medications, and Others}), By Type (Autistic Disorder, Asperger Syndrome, Pervasive Developmental Disorder, and Others), and Regional Forecast, 2025-2032

ATTRIBUTE

DETAILS

Study Period

2019-2032

Base Year

2024

Estimated Year 

2025

Forecast Period

2025-2032

Historical Period

2019-2023

Growth Rate

CAGR of 8.7% from 2025 to 2032

Unit

Value (USD billion)

Segmentation

By Treatment Type

• Communication & Behavioral Therapies
  • Applied Behavior Analysis (ABA)
  • Speech & Language Therapy
  • Occupational Therapy
  • Others
• Drug Therapies
  • Antipsychotic Drugs
  • SSRIs/Antidepressants
  • Stimulants
  • Sleep Medications
  • Others

By Type

• Autistic Disorder
• Asperger Syndrome
• Pervasive Developmental Disorder (PDD)
• Others

By Geography

• North America (By Treatment Type, Type, and Country)
  • U.S.
  • Canada
• Europe (By Treatment Type, Type, and Country/Sub-Region)
  • U.K.
  • Germany
  • France
  • Italy
  • Spain
  • Scandinavia
  • Rest of Europe
• Asia Pacific (By Treatment Type, Type, and Country/Sub-Region)
  • China
  • Japan
  • India
  • Australia
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America (By Treatment Type, Type, and Country/Sub-Region)
  • Brazil
  • Mexico
  • Rest of Latin America
• The Middle East & Africa (By Treatment Type, Type, and Country/Sub-Region)
  • GCC Countries
  • South Africa
  • Rest of the Middle East & Africa